Lupin Q2 Net Profit Declines 22.19% to Rs 1,155.3 Crore Amid Revenue Growth
Lupin reported a 22.19% decline in consolidated net profit to Rs 1,155.3 crore for the September quarter, impacted by an exceptional item. Revenue rose to Rs 7,827.26 crore, while expenses increased to Rs 6,374.46 crore. For the six months ended September 2026, net profit fell 4.95% to Rs 2,572.28 crore. The company settled a US antitrust case for Rs 316.28 crore without admitting liability. US sales grew 9.3%, and India sales increased 14.7%, maintaining Lupin's position as the third-largest pharmaceutical player in the US market.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (58/100). Lens Score 37/100.
Outlets measured: english, mint, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (55–62/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 3 Nov, 09:00 pm. Other outlets followed.